Mr Ho was appointed as the Non-Executive Chairman of the Company on 2 April 2015. Prior to this, Mr Ho served as the Non-Executive Vice-Chairman of the Company since 1 October 2007.
Mr Ho has accumulated extensive experience during his tenure as Chief Executive Officer of Singapore-incorporated Tai Tak Estates Sendirian Berhad (“Tai Tak”), having been involved in its businesses, including in plantations, listed and private equities, and property holding and development. He has also been instrumental in assisting the Group’s senior management in the conceptualisation and setting of the strategic direction and corporate values of the Group.
Mr Ho holds a Higher National Diploma in Business Studies from Polytechnic of The South Bank, United Kingdom.
Mr Ho was appointed as an Alternate Director to Mr Ho Han Leong Calvin on 19 May 2014. He is currently holding the position of Executive Vice-President of Tai Tak, where he is responsible for overseeing Tai Tak group's overall business and financial strategy, investments and operations.
Mr Ho holds a Bachelor of Social Sciences Degree with Honours from the National University of Singapore.
Mr Kwek was appointed as a Non-Executive Director of the Company on 5 March 2019, as the representative of City Developments Limited and Hong Leong Investment Holdings Pte. Ltd.. He sits on the boards of various non- listed subsidiaries within Hong Leong Group Singapore, and is also a Governor of Hong Leong Foundation.
Mr Kwek is a private investor who invests in disruptive and frontier technologies, and a cryptocurrency entrepreneur. He is an owner of Superp (ticker: SUP), a decentralized crypto derivatives exchange with a trading platform for both highly leveraged short and long positions.
Mr Kwek holds a Masters in Politics from Columbia University, a Bachelor's in Finance from the Wharton School, and a second Bachelor's from the College, both at the University of Pennsylvania. He also studied in Beijing University and Moscow State University, and has lived and worked in Washington New York, and Tokyo.
Mr Neo was appointed as the Group Chief Executive Officer and Executive Director of the Company on 1 October 2007. He has overall responsibility for management, operations and growth of the Group’s businesses. Mr Neo was appointed as a member of the Supervisory Board of NSI N.V. on 30 September 2024. NSI N.V. is listed on Euronext Amsterdam and has a property portfolio of 42 office properties across The Netherlands.
Mr Neo began his career with KPMG in 1994. In 1996, he joined Hong Leong Group Singapore and held various roles within Hong Leong Group Singapore. He was also previously the board member of various entities within Hong Leong Group Singapore.
Mr Neo holds a Bachelor of Accountancy Degree (First Class Honours) from Nanyang Technological University, Singapore.
Mr Wee was appointed as a Lead Independent Director of the Company with effect from 25 April 2024 and has been a Director of the Company since 6 February 2017.
Mr Wee is a partner and head of the Corporate Commercial Practice Group and also Co-Head of the Employment Practice Group of Rajah & Tann Singapore LLP specialising in mergers and acquisitions, general commercial law and employment law. He also has a particular focus in foreign direct investments into the emerging Asian economies. Mr Wee also has prior experience as a litigator as well as being the group regional legal counsel of a Hong Kong public listed company.
Mr Wee is currently the Non-Executive Director of Spartans Rugby Singapore Limited.
Mr Wee graduated with a Bachelor of Laws (Honours) from the University of Nottingham in 1994 and is admitted as an Advocate and Solicitor of the Supreme Court of Singapore and as a Barrister-at-law, Middle Temple in the United Kingdom.
Ms Tan was appointed as the Independent Non-Executive Director of the Company and Chairperson of the Audit and Risk Committee with effect from 15 March 2023.
Ms Tan has more than 20 years of accounting and auditing experience and previously served as an audit and advisory partner with KPMG LLP from 2003 to 2010. During her service in KPMG LLP, she provided accounting and advisory services to clients in both private and public sectors. Since her retirement as a practising accountant, Ms Tan, at the request of KPMG, served as principal advisor from 2010 to 2011 on matters related to the healthcare industry, and assisted the firm in establishing the AsPAC Healthcare network. She also contributed to academia as an adjunct professor at the Nanyang Technological University from 2009 to 2018 and has also been contributing actively to the non-profit sector through her appointments at various charities and government affiliated organisations.
Amongst others, Ms Tan currently serves as an Independent Director of Oiltek International Limited, a Singapore listed company. She is also a director of Accuron Technologies Limited, Singapore Aerospace Manufacturing Pte. Ltd., and Sheares Healthcare Group Pte Ltd, all of which are subsidiaries of Temasek Holdings. In addition, she serves as a director of PUB, Singapore's National Water Agency, where she is chairperson of the Audit Committee and a member of Human Resource Committee. She also sits on the boards of Ren Ci Hospital and TTSH Community Fund.
Ms Tan graduated with First Class Honours in Accountancy from Nanyang Technology University, is a Fellow and non- practising member of the Institute of Singapore Chartered Accountants and a member of the Singapore Institute of Directors.
Ms Low was appointed as an Independent Non-Executive Director of the Company with effect from 15 March 2024. With over 30 years of extensive experience, Ms Low brings a wealth of expertise in various fields, including finance, investments, treasury, fund raising, and asset management.
Ms Low previously served as the Chief Financial Officer of Changi Airports International Pte Ltd (“CAI”). During her tenure at CAI, she also sat on the boards of several CAI’s investee companies. Earlier in her career, she held senior roles in multinational and publicly listed companies, including DBS Bank and Millennium & Copthorne Hotels in London.
Ms Low holds a Bachelor of Accountancy from the National University of Singapore and a Bachelor of Laws from the University of London. She has also completed the CoreStates Advanced Management Program for Overseas Bankers from the Wharton School, University of Pennsylvania.
Mr Lim is appointed as an Independent Director of the Company with effect from 16 March 2026.
Mr Lim is a Partner and Co-Head of the Medical, Healthcare & Life Sciences Practice at Rajah & Tann Singapore LLP. He is also Regional Head of the Mergers & Acquisitions Practice at Rajah & Tann Asia, and a Partner at Christopher & Lee Ong (Malaysia), the Malaysian member firm of Rajah & Tann Asia. In addition, Mr Lim serves as an Executive Committee Member of Rajah & Tann LCT Lawyers (Vietnam).
Mr Lim has over 35 years of experience in advising companies on multi-jurisdictional cross-border investments, private mergers and acquisitions, sale and purchase of companies and businesses and other corporate transactions. He has been consistently recognised as a leading lawyer by legal directories such as Chambers Asia-Pacific, The Legal 500 Asia- Pacific, IFLR1000 and asialaw. His expertise also extends to advising numerous biotechnology, health and pharmaceutical global leaders on cross-border acquisitions and divestments. Most recently, he was recognised as a Global Elite Thought Leader for Life Sciences by Who’s Who Legal.
Mr Lim currently serves as a non-Executive Director of A. Menarini Asia-Pacific Holdings Pte Ltd., a pharmaceutical company operating in 13 markets in the Asia Pacific region. Between September 2014 to April 2024, Mr Lim was also an Independent Director of ISEC Healthcare Ltd, a company listed on the Catalist Board of SGX and served as Chairman of the Nominating and Remuneration Committees as well as member of the Audit Committee.
Mr Lim graduated with a Bachelor of Laws (Honours) from the National University of Singapore. He is admitted as an Advocate & Solicitor of Singapore and Malaysia and is also admitted as a Solicitor of England & Wales (non-practising).